Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Manuela Tumiati
Observed names:
M Tumiati,
M. Tumiati,
M.N. Tumiati,
Manuela Tumiati (15011915),
Tumiati M.,
Tumiati, Manuela
show all 6
Observed institutions:
University of Helsinki,
Cancer Research UK,
Cancer Research UK Cambridge Center,
Institute for Molecular Medicine Finland,
National Institute of Radiological Sciences,
Institute for Radiological Science
show all 6
ORCID:
0000-0003-4889-3445
Observed ORCID:
0000-0003-4889-3445
OpenAlex ID:
A5040908201
Targeting BRCA1 and BRCA2 Deficiencies with G-Quadruplex-Interacting Compounds
2015
·
Jutta Zimmer
, Eliana M.C. Tacconi
, et al.
·
Molecular Cell
·
257
PDF
A Functional Homologous Recombination Assay Predicts Primary Chemotherapy Response and Long-Term Survival in Ovarian Cancer Patients
2018
·
Manuela Tumiati
, Sakari Hietanen
, et al.
·
Clinical Cancer Research
·
106
40th EASD Annual Meeting of the European Association for the Study of Diabetes
2004
·
M. Veitenhansl
, K. Stegner
, et al.
·
Diabetologia
·
67
Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer
2022
·
Fernando Perez-Villatoro
, Jaana Oikkonen
, et al.
·
npj Precision Oncology
·
46
PDF
MCM3AP in recessive Charcot-Marie-Tooth neuropathy and mild intellectual disability
2017
·
Emil Ylikallio
, Rosa Woldegebriel
, et al.
·
Brain
·
41
PDF
Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
2023
·
Sanna Pikkusaari
, Manuela Tumiati
, et al.
·
Clinical Cancer Research
·
29
PDF
Transcription Factor USF1 Is Required for Maintenance of Germline Stem Cells in Male Mice
2019
·
Imrul Faisal
, Sheyla Cisneros-Montalvo
, et al.
·
Endocrinology
·
22
PDF
Targeting DNA Homologous Repair Proficiency With Concomitant Topoisomerase II and c-Abl Inhibition
2021
·
Arafat Siddiqui
, Manuela Tumiati
, et al.
·
Frontiers in Oncology
·
9
Parity associates with chromosomal damage in uterine leiomyomas
2021
·
Heli Kuisma
, Simona Bramante
, et al.
·
Nature Communications
·
9
PDF
Loss of Rad51c accelerates tumourigenesis in sebaceous glands of Trp53‐mutant mice
2014
·
Manuela Tumiati
, Annabrita Hemmes
, et al.
·
The Journal of Pathology
·
8
TP53 supports basal-like differentiation of mammary epithelial cells by preventing translocation of deltaNp63 into nucleoli
2014
·
Pauliina M. Munne
, Yuexi Gu
, et al.
·
Scientific Reports
·
7
PDF
Drug screening approach combines epigenetic sensitization with immunochemotherapy in cancer
2019
·
Chiara Facciotto
, Julia Casado
, et al.
·
Clinical Epigenetics
·
5
PDF
Rad51c- and Trp53-double-mutant mouse model reveals common features of homologous recombination-deficient breast cancers
2016
·
M Tumiati
, P M Munne
, et al.
·
Oncogene
·
5
Length of ischemic time is critical for accurate determination of homologous recombination capacity by immunostaining in FFPE tumor samples
2024
·
Ezgi Karagöz
, Sanna Pikkusaari
, et al.
·
medRxiv
·
1
PDF
Data from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
2023
·
Sanna Pikkusaari
, Manuela Tumiati
, et al.
·
1
Time to go functional! Determining tumors’ DNA repair capacityex vivo
2018
·
Manuela Tumiati
, Sakari Hietanen
, et al.
·
Oncotarget
·
1
PDF
Supplementary Table S1 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
2025
·
Sanna Pikkusaari
, Manuela Tumiati
, et al.
Supplementary Figure S7 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
2025
·
Sanna Pikkusaari
, Manuela Tumiati
, et al.
PDF
Supplementary Figure S4 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
2025
·
Sanna Pikkusaari
, Manuela Tumiati
, et al.
PDF
Supplementary Figure S3 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
2025
·
Sanna Pikkusaari
, Manuela Tumiati
, et al.
PDF
Supplementary Figure S2 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
2025
·
Sanna Pikkusaari
, Manuela Tumiati
, et al.
Supplementary Table S2 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
2025
·
Sanna Pikkusaari
, Manuela Tumiati
, et al.
Supplementary Figure S6 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
2025
·
Sanna Pikkusaari
, Manuela Tumiati
, et al.
PDF
Supplementary Figure S1 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
2025
·
Sanna Pikkusaari
, Manuela Tumiati
, et al.
PDF
Supplementary Figure S8 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
2025
·
Sanna Pikkusaari
, Manuela Tumiati
, et al.
PDF
Show more works
View as search
Works count:
98
Citation count:
614
H-index:
9
I10-index:
7
Year
Topic
Type